Wade Smith(University of California San Francisco) : The diagnosis of ischemic and cryptogenic stroke

Mintu Turakhia(Stanford University Stanford) : Prevalence of ICH and role of OAC in preventing ischemic stroke

Michel Barakat(Health University of Utha) : Role of atrial fibrosis in stroke and AF

Gregory Marcus(University of California San Francisco) : AF Monitoring devices – What information do they provide for strokeprevention

James Cox(Northwestern University Chicago) : Can sinus rhythm be obtained in persistent and longstanding persistent AF?Implications for stroke prevention

David Wilber(Loyola University Medical Center Hines) : Implication of AF ablation studies? (Crystal AF, aMAZE, Cabanan, East)

Maurice Buchbinder(San Diego Cardiovascular Associates Foundation for Cardiovascular Medicine) : Rationale for LAA occlusion in the prevention of stroke – Efficacy, safety and cost benefits

Jonathan Hsu(University of California San Diego) : Should an epicardial LAA approach be considered in patients with contraindications to OAC therapy?

John Carroll(University of Colorado Hospital) : PFO closure: the long journey from experimental medicine to a class IArecommendation

James Freeman(Yale University) : Should LAA closure be performed routinely during surgery? Impact on stroke

Guy Shinar(Javelin Medical) : A new minimally invasive concept for permanent stroke prevention

Horst Sievert(Cardiovascular Center Frankfurt) : Recorded case: PFO closure with Amplatzer PFO occluder - step by step

David Wilber(Loyola University Medical Center) : How do you prevent stroke in the anticoagulation contraindicated patient?

David Holmes(Mayo Clinic) : How serious is device related thrombus? Real life perspective.

James Cox(Northwestern University) : LAA closure and leaks: What is the significance?

Edward Gerstenfeld(University of California San Francisco) : Should AF ablation be used to prevent CHF?

Byron Lee(University of California San Francisco) : Vest predicts: what did we learn?

Mark La Meir(Academic Hospital Maastricht) : Surgical Treatment of inappropriate sinus tachycardia and POTTS syndrome

Jayanthi Koneru(VCU Health) : His Bundle pacing instead of CRT?

Yuval Binur(Arsuf Partners) : CV innovations - where are we heading to in the changing world

Peter Fitzgerald(Stanford University) : What could be the next really ground breaking innovations in cardiovascularmedicine?

Vijay Swarup(Arizona Heart Rhythm Center) : Live transmission from Arizona Heart Rhythm Center, Phoenix, USA

Krzysztof Bartus(Jagiellonian University) : LAA closure with LARIAT: influence on hormonal regulation and coagulation

David Holmes(Mayo Clinic) : Real World Experience for LAA closure

Michael Hoskins(Emory Heart & Vascular Center at Clifton) : Does LAA closure for the treatment of AF make sense?

Jonathan Hsu(University of California San Diego) : Is there a role for LAA closure devices and low dose OAC therapy?

Jacqueline Saw(Vancouver General Hospital) : LAA US trials: Ongoing and future trials

Randall Lee(University of California San Francisco) : Case presentations of different LAA cases – Determination of the optimal LAA closure device

Karl Meisel(University of California San Francisco) : A deep dive into the Amplatzer PFO trials

Matthew Price(Scripps Clinic) : REDUCE deep dive

John Rhodes(Medical University of South Carolina), Jr. : matters

Matthew Price(Scripps Clinic) : doesn’t matter

Matthew Price(Scripps Clinic) : Atrial fibrillation after PFO closure: how frequent? How to deal with it? What isthe prognosis?

John Rhodes(Medical University of South Carolina), Jr. : CARDIOFORM vs. Helex closure rate

Keshav Nayak(Naval Medical Center San Diego) : Should we close PFOs in divers before something happens?